[HTML] mdpi.com

[HTML][HTML] Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS Moraes, CBC Sena, JLM Nascimento… - Pathogens, 2022 - mdpi.com
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …
被引用次数：1 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp. Pathogens 2022, 11, 925

JAL Pereira, LS Moraes, CBC Sena, JLM Nascimento… - 2022 - pdfs.semanticscholar.org
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS de Moraes, CBC de Sena… - agris.fao.org
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp

JAL Pereira, LS de Moraes… - Pathogens (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS Moraes, CBC Sena… - …, 2022 - search.ebscohost.com
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS Moraes, CBC Sena… - Pathogens (Basel …, 2022 - europepmc.org
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS de Moraes, CBC de Sena… - …, 2022 - search.proquest.com
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

Inhibition of melanization by kojic acid promotes cell wall disruption of the human pathogenic fungus Fonsecaea sp.

JAL Pereira, LS de Moraes, CBC de Sena… - 2022 - cabidigitallibrary.org
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …
[HTML] nih.gov

[HTML][HTML] Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS de Moraes, CBC de Sena… - Pathogens, 2022 - ncbi.nlm.nih.gov
Chromoblastomycosis (CBM) is a chronic human subcutaneous mycosis caused by various
aetiologic agents. CBM does not have an established treatment but may be managed using …

[引用][C] Inhibition of Melanization by Kojic Acid Promotes Cell Wall Disruption of the Human Pathogenic Fungus Fonsecaea sp.

JAL Pereira, LS de Moraes, CBC de Sena… - 2022